The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Natural history and risk-stratification of biochemical recurrence in prostate cancer treated with definitive radiotherapy.
 
Paul Riviere
No Relationships to Disclose
 
Kylie Morgan
No Relationships to Disclose
 
Tyler Nelson
No Relationships to Disclose
 
Daniel Sabater Minarim
No Relationships to Disclose
 
Leah Deshler
No Relationships to Disclose
 
Matthew Banegas
No Relationships to Disclose
 
Tyler Stewart
Consulting or Advisory Role - AstraZeneca; Seattle Genetics/Astellas
Research Funding - GRAIL
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Juan Javier-Desloges
No Relationships to Disclose
 
Kellogg Parsons
Employment - Janssen Research & Development; MBrace Therapeutics
Stock and Other Ownership Interests - Bluebird Bio; Moderna Therapeutics; Omega Healthcare Investors; Urigen Pharmaceuticals
 
Brent Rose
Employment - UC San Diego Health